Jazz Pharmaceuticals PLCJazz Pharmaceuticals PLC - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This Disclosure score includes seventeen UN SDGs including: 'Good Health & Wellbeing', 'Reduced Inequalities' and 'Partnerships for the Goals'. The report of Jazz Pharmaceuticals PLC was prepared by All Street Sevva using proprietary AI. Detailed Sustainability analysis of Jazz Pharmaceuticals PLC are reached by signing up for free.

Jazz Pharmaceuticals PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.

SDG Transparency Score for Jazz Pharmaceuticals PLC 
Low
0 - 3
Medium
4 - 6

8.0

High Impact
7 - 10
Last Score Update: 2024-05-01
What drives the score for Jazz Pharmaceuticals PLC 
8.0

Environmental

8.0

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Jazz Pharmaceuticals PLC
8.0
High
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
.........
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Jazz Pharmaceuticals PLC have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC report the average age of the workforce?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose cybersecurity risks?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC offer flexible work?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC conduct supply chain audits?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose water use targets?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Jazz Pharmaceuticals PLC have a product recall in the last two years?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose incidents of discrimination?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Jazz Pharmaceuticals PLC issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose parental leave metrics?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Jazz Pharmaceuticals PLC involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose its waste policy?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC report according to TCFD requirements?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose energy use targets?

LockedSign up for free to unlock

Does Jazz Pharmaceuticals PLC disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Jazz Pharmaceuticals PLC have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Jazz Pharmaceuticals PLC
These potential risks are based on the size, segment and geographies of the company.

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic and solid tumors. Its lead marketed products include Xyrem, an oral solution for the treatment of cataplexy and excessive daytime sleepiness (EDS) in narcolepsy patients seven years of age and older; Sunosi for the treatment of EDS in patients with narcolepsy and obstructive sleep apnea; Erwinaze to treat acute lymphoblastic leukemia; Defitelio for the treatment of adult and pediatric patients with hepatic veno-occlusive disease; Vyxeos liposome for injection, a product for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia; and Zepzelca for the treatment of adult patients with metastatic small cell lung cancer. The company also offers Xywav, an oxybate product candidate, to treat EDS and cataplexy with narcolepsy and idiopathic hypersomnia; JZP-324, a low sodium oxybate formulation with the potential to provide a clinically meaningful option for narcolepsy patients; JZP385, a T-type calcium channel modulator, for the treatment of essential tremor; JZP458, a recombinant Erwinia asparaginase, for use as a component of a multi-agent chemotherapeutic regimen in the treatment of pediatric and adult patients; and JZP150 for treatment of post-traumatic stress disorder. The company has licensing and collaboration agreements with ImmunoGen, Inc.; Codiak BioSciences, Inc.; Pfenex, Inc.; XL-protein GmbH; and Redx Pharma plc. Jazz Pharmaceuticals plc was incorporated in 2003 and is headquartered in Dublin, Ireland.

Sorry!

Failed to process!